• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CWBR

CWBR

CohBar, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.41

+0.00 (+0.00%)

Company Profile

CEO

Pinchas Cohen Dean,

IPO Date

2017-12-15

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.41

Prev. Close

$0.41

Day Low

$0.41

Day High

$0.41

52W Low

$0.00

52W High

$1.01

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.1%

Avg Negative

5.1%

Avg Neutral

65.8%

News Feed

CohBar Appoints Carol Nast to Its Board of Directors

GlobeNewsWire·8/16/2021·↑ positive

CohBar Shares Increased 25.58%: Why It Happened

Pulse2·8/12/2021·↑ positive

CWBR Stock Price Increases Over 75% Intraday: Why It Happened

Pulse2·8/11/2021·↑ positive

CohBar's (CWBR) CEO Joe Sarret on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/10/2021·↓ negative

CohBar Reports Second Quarter 2021 Financial Results and Provides Business Update

GlobeNewsWire·8/10/2021·↓ negative

CohBar Announces Positive Topline Results from the Phase 1a/1b Study of CB4211 Under Development for NASH and Obesity

GlobeNewsWire·8/10/2021·↑ positive

CohBar Stock Slumps As Data From NASH, Obesity Candidate Delayed By Almost Two Months

Benzinga·7/14/2021·↑ positive

CohBar Provides Update on the Phase 1a/1b Clinical Trial for CB4211 Under Development for NASH and Obesity

GlobeNewsWire·7/14/2021·↑ positive

CohBar, Inc. (CWBR) CEO Joe Sarret on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/17/2021·↓ negative

CohBar Appoints Joseph J. Sarret, M.D.

GlobeNewsWire·4/27/2021·↓ negative